Michael G. Grey, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 14,608 shares at $32.00 ($467K) on 2023-09-14, disclosed to the SEC on 2023-09-14.
Open-market sale of $467k MIRM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.00 | 392 | $13K | 2.7% |
| 2 | $32.00 | 14,216 | $455K | 97.3% |
| Total | $32.00 avg | 14,608 | $467K | 100% |
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |
| MIRM | SELL | 2023-05-04 | $409K | — | Filing → |